Register for our Rare Diseases and Hormone Disorders webinar series to strengthen your expertise in evidence-based diagnosis, management, and long-term care of rare endocrine conditions and hormone disorders.
This free 6-part live webinar series will cover the following topics:
- Managing TED in Practice: Expanding the Endocrinologist’s Scope
- Paresthesias Muscle Spasms and Cramps: Unraveling the Hypocalcemia Puzzle in Hypoparathyroidism
- Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment
- When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia
- Cortisol Deficiency and Androgen Excess: Navigating the Challenges of CAH
- Polycystic Ovary Syndrome
These diseases were chosen due to their rarity, symptom complexity, and need for improved diagnostic and management strategies. The series will provide clinicians with the latest clinical guidance and educational resources for diagnosing, managing, and treating these conditions. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with these rare endocrine diseases and hormone disorders.
Date: 10/3/2025 | 1:00 PM EDT - 2:00 PM EDT
CME/MOC/Nursing: 1 Credit
Upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with thyroid eye disease.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat thyroid eye disease.
- Identify and treat long-term complications and comorbidities of thyroid eye disease.
SPEAKERS
FACULTY
Christian Nasr, MD, FACE, FACP
Endocrinologist
Banner Health
Phoenix, AZ
Malini Gupta, MD, ECNU, FACE, FITS
Director of G2Endo
Endocrinology & Metabolism
Memphis, TN
This activity is supported by an independent educational grant from Amgen Inc.
RegisterDate: 10/10/2025 | 1:00 PM EDT - 2:00 PM EDT
CME/MOC/Nursing: 1 Credit
Upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with hypoparathyroidism.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat hypoparathyroidism.
- Identify and treat long-term complications and comorbidities of hypoparathyroidism.
SPEAKERS
FACULTY
Inderpreet Madahar, MD
Assistant Professor
Corewell Health Lakeland Hospitals
St. Joseph, MI
Aliya Khan, MD, FRCPC, FACP, FACE
Professor of Clinical Medicine
Divisions Endocrinology and Metabolism and Geriatrics
Director, Fellowship in Metabolic Bone Disease
Director, Calcium Disorders Clinic
McMaster University
Oakville, ON
This activity is supported by educational grants from Ascendis Pharma.
RegisterDate: 10/24/2025 | 1:00 PM EDT - 2:00 PM EDT
CME/MOC/Nursing: 1 Credit
Upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with homozygous familial hypercholesterolemia.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat homozygous familial hypercholesterolemia.
- Identify and treat long-term complications and comorbidities of homozygous familial hypercholesterolemia.
SPEAKERS
FACULTY
Eliot Brinton, MD, FAHA, FNLA, FACE
Past President, American Board of Clinical Lipidology
President, Utah Lipid Center
Salt Lake City, Utah
Lance Sloan, MD, MSE, FACE, FASN, FACP, FEAA, FASPC
Medical Director, Texas Institute for Kidney and Endocrine Disorders
Lufkin, TX 75904
This activity is supported by educational grants from Amgen Inc, Regeneron, and Chiesi USA.
RegisterDate: 10/31/2025 | 11:00 AM EDT - 12:00 PM EDT
CME/MOC/Nursing: 1 Credit
Upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with severe hypertriglyceridemia.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat severe hypertriglyceridemia.
- Identify and treat long-term complications and comorbidities of severe hypertriglyceridemia.
SPEAKER
FACULTY
Robert H. Eckel, MD
Professor of Medicine, Emeritus
Division of Endocrinology, Metabolism & Diabetes
Division of Cardiology
S/P Professor of Physiology & Biophysics
S/P Charles A. Boettcher II Chair in Atherosclerosis
University of Colorado Anschutz Medical Campus
Past President, North American Association for the Study of Obesity (AKA The Obesity Society)
Past President, American Heart Association
Past President Medicine and Science, American Diabetes Association
This activity is supported by an independent educational grant from Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals.
RegisterDate: 10/31/2025 | 1:00 PM EDT - 2:00 PM EDT
CME/MOC/Nursing: 1 Credit
Upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with congenital adrenal hyperplasia.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat congenital adrenal hyperplasia.
- Identify and treat long-term complications and comorbidities of congenital adrenal hyperplasia.
SPEAKER
FACULTY
Ricardo Correa, MD, EdD, FACE, FACP, FAPCR, FACMQ
Program Director, Endocrinology, Diabetes and Metabolism Fellowship
Cleveland Clinic
Cleveland, OH
This activity is supported by an independent educational grant from Neurocrine Biosciences Inc.
RegisterDate: 11/7/2025 | 1:00 PM EDT - 2:00 PM EDT
CME/MOC/Nursing: 1 Credit
Upon completion of the program, participants will be able to:
- Identify key clinical indicators and appropriate screening protocols for polycystic ovary syndrome in women to improve diagnostic accuracy and reduce care delays.
- Evaluate and implement evidence-based treatment options, including lifestyle, hormonal, and pharmacological interventions, to develop personalized and comprehensive management plans.
- Recognize the long-term health risks associated with polycystic ovary syndrome and describe preventive care strategies to mitigate these risks and optimize patient outcomes.
SPEAKER
FACULTY
Jessica Abramowitz, MD
Associate Professor
Associate Program Director, Endocrinology and Metabolism Fellowship Program
UT Southwestern Medical Center
Dallas, TX
This activity is supported by an independent educational grant from Dexcom, Inc.
Registration Coming SoonFor each module, upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with a rare endocrine disease.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat rare endocrine diseases.
- Identify and treat long-term complications and comorbidities of rare endocrine diseases.
Endocrinologists are the primary target audience; however, all healthcare professionals, including primary care physicians, nurse practitioners, nurses, physician associates and endocrine care professionals who treat patients with rare endocrine diseases in their practice may also access this program.